drugset / Trial / NCT02952040

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate

NCT02952040

Phase 1 Completed 18 enrolled Astellas Pharma Inc Kyntra Bio · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The objective of this study is to evaluate the effect of lanthanum carbonate hydrate on the pharmacokinetics (PK) of ASP1517 in non-elderly healthy male subjects.

Timeline

Start
2016-11
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lanthanum Carbonate Other / unclassified Oral
Subject Roxadustat Small molecule Oral

Indications

No indication recorded.